The Ubiquitin Proteasome System in Quality Control

泛素蛋白酶体系统在质量控制中的应用

基本信息

  • 批准号:
    7616236
  • 负责人:
  • 金额:
    $ 25.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Production of folding-defective proteins underlies the pathogenesis of many heritable disorders in man, yet the unique features of misfolded proteins and the cellular machinery that recognizes them remain largely unknown. The long-term goal of this project is to identify the cellular factors that couple the recognition of folding-defective proteins in the endoplasmic reticulum to their degradation by a process known as ER-associated degradation (ERAD). Despite considerable progress made in linking the cytoplasmic ubiquitin-proteasome system (UPS) to ERAD, fundamental questions remain unanswered. Foremost amongst these is the nature of the cis and trans signals that identify a protein as an ERAD substrate and the molecular events that divert proteins from the biosynthetic folding pathway to ERAD. Previous work from my lab and many others has firmly established a central role for the UPS in the targeting of misfolded ER proteins for degradation. The immediate goal of this project is thus to identify the cellular machinery by which malfolded proteins in the ER are recognized. We will use a combination of functional genomics and traditional cell biology to identify E3 Ub ligases and other critical elements of the UPS that collaborate in the recognition of ERAD substrates. To this end, three specific aims are proposed. In the first aim we plan to screen libraries of small hairpin interfering RNA (shRNA) directed against all probable UPS components in the human genome. Hits from this screen will be validated by a battery of assays and the interaction of the newly identified components with substrate and other ERAD machinery will be studied in detail. Preliminary data are included identifying Hrd1 as an E3 ligase for degradation of unassembled AMPA-type glutamate receptor subunits, thereby validating the efficacy of our functional genomics screen. Thus, the second aim is to elucidate the cis- and trans- acting factors that promoting Hrd1- dependent degradation of GluR1 subunits. The third aim complements the first by performing a comprehensive biochemical and microarray investigation of how cellular stress response pathways respond to topologically and structurally distinct classes of ERAD substrate. It is anticipated that this analysis will provide new understanding of how cells respond to physiologically relevant protein stress, and will facilitate the identification of new components of that direct specific classes of substrate to degradation by ERAD.
描述(由申请人提供):折叠缺陷蛋白质的产生是人类许多遗传性疾病发病机制的基础,但错误折叠蛋白质的独特特征和识别它们的细胞机制在很大程度上仍然未知。该项目的长期目标是确定将内质网中折叠缺陷蛋白的识别与其降解过程(称为ER相关降解(ERAD))相结合的细胞因子。尽管在细胞质泛素-蛋白酶体系统(UPS)与ERAD的联系方面取得了相当大的进展,但基本问题仍然没有答案。其中最重要的是识别蛋白质作为ERAD底物的顺式和反式信号的性质,以及将蛋白质从生物合成折叠途径转移到ERAD的分子事件。我的实验室和许多其他实验室的先前工作已经牢固地确立了UPS在靶向错误折叠的ER蛋白降解中的核心作用。因此,该项目的直接目标是确定识别ER中错误折叠蛋白质的细胞机制。我们将使用功能基因组学和传统的细胞生物学相结合,以确定E3 Ub连接酶和其他关键要素的UPS,在ERAD基板的识别合作。为此,提出了三个具体目标。在第一个目标中,我们计划筛选针对人类基因组中所有可能的UPS组分的小发夹干扰RNA(shRNA)文库。将通过一系列试验验证该筛选的结果,并详细研究新鉴定的组分与底物和其他ERAD机制的相互作用。初步数据包括识别Hrd 1作为E3连接酶的未组装的AMPA型谷氨酸受体亚基的降解,从而验证我们的功能基因组学筛选的功效。因此,第二个目标是阐明促进Hrd 1依赖性GluR 1亚基降解的顺式和反式作用因子。第三个目标是通过进行全面的生物化学和微阵列研究来补充第一个目标,研究细胞应激反应途径如何响应拓扑和结构不同的ERAD底物。预计这种分析将提供新的理解细胞如何响应生理相关的蛋白质压力,并将有助于识别新的成分,直接特定类别的底物降解ERAD。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RON R KOPITO其他文献

RON R KOPITO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RON R KOPITO', 18)}}的其他基金

The role of UFMylation in ribosome quality control at the ER
UFMylation 在 ER 核糖体质量控制中的作用
  • 批准号:
    10561470
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8686087
  • 财政年份:
    2012
  • 资助金额:
    $ 25.75万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    9098811
  • 财政年份:
    2012
  • 资助金额:
    $ 25.75万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8401724
  • 财政年份:
    2012
  • 资助金额:
    $ 25.75万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8490454
  • 财政年份:
    2012
  • 资助金额:
    $ 25.75万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    8462992
  • 财政年份:
    2006
  • 资助金额:
    $ 25.75万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    9912161
  • 财政年份:
    2006
  • 资助金额:
    $ 25.75万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    8260579
  • 财政年份:
    2006
  • 资助金额:
    $ 25.75万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    10193992
  • 财政年份:
    2006
  • 资助金额:
    $ 25.75万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    7887688
  • 财政年份:
    2006
  • 资助金额:
    $ 25.75万
  • 项目类别:

相似海外基金

CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
  • 批准号:
    2339759
  • 财政年份:
    2024
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Continuing Grant
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
  • 批准号:
    2320160
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Standard Grant
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
  • 批准号:
    23H02481
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
  • 批准号:
    479334
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Operating Grants
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
  • 批准号:
    10655891
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
  • 批准号:
    10716621
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
  • 批准号:
    10637251
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
  • 批准号:
    10604822
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
  • 批准号:
    10621634
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
  • 批准号:
    22KJ2600
  • 财政年份:
    2023
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了